{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T03:40:38Z","timestamp":1769485238509,"version":"3.49.0"},"reference-count":18,"publisher":"Editorial Committee of Annals of Thoracic and Cardiovascular Surgery","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ATCS","Ann Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5761\/atcs.cr.25-00214","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:09:14Z","timestamp":1769119754000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Conversion to Complete, Parenchyma-Sparing Resection after Prolonged Denosumab for Bilateral Multifocal Pulmonary Metastases from Giant Cell Tumor of Bone: A Case Report"],"prefix":"10.5761","volume":"32","author":[{"given":"Seiji","family":"Omura","sequence":"first","affiliation":[{"name":"Department of General Thoracic Surgery, Tokyo Dental College, Ichikawa General Hospital, Ichikawa, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Tokyo Dental College, Ichikawa General Hospital, Ichikawa, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ukei","family":"Anazawa","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Tokyo Dental College, Ichikawa General Hospital, Ichikawa, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of General Thoracic Surgery, Tokyo Dental College, Ichikawa General Hospital, Ichikawa, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3757","reference":[{"key":"1","unstructured":"1) WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours. 5th ed. Lyon: IARC; 2020."},{"key":"2","unstructured":"2) Sobti A, Agrawal P, Agarwala S, et al. Giant cell tumor of bone\u2014an overview. Arch Bone Jt Surg 2016; 4: 2\u20139."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Chan CM, Adler Z, Reith JD, et al. Risk factors for pulmonary metastases from giant cell tumor of bone. J Bone Joint Surg Am 2015; 97: 420\u20138.","DOI":"10.2106\/JBJS.N.00678"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Yang Y, Huang Z, Niu X, et al. Clinical characteristics and risk factors analysis of lung metastasis from benign giant cell tumor of bone. J Bone Oncol 2017; 7: 23\u20138.","DOI":"10.1016\/j.jbo.2017.04.001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Behjati S, Tarpey PS, Presneau N, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 2013; 45: 1479\u201382.","DOI":"10.1038\/ng.2814"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Amary F, Berisha F, Ye H, et al. H3F3A (Histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone. Am J Surg Pathol 2017; 41: 1059\u201368.","DOI":"10.1097\/PAS.0000000000000859"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Schaefer IM, Fletcher JA, Nielsen GP, et al. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy. Cancer Cytopathol 2018; 126: 552\u201366.","DOI":"10.1002\/cncy.22000"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Thomas D, Henshaw R, Skubitz K, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 2010; 11: 275\u201380.","DOI":"10.1016\/S1470-2045(10)70010-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Chawla S, Henshaw R, Seeger L, et al. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol 2013; 14: 901\u20138.","DOI":"10.1016\/S1470-2045(13)70277-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Chawla S, Blay J-Y, Rutkowski P, et al. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. Lancet Oncol 2019; 20: 1719\u201329.","DOI":"10.1016\/S1470-2045(19)30663-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Errani C, Tsukamoto S, Leone G, et al. Denosumab may increase the risk of local recurrence in patients with giant-cell tumor of bone treated with curettage. J Bone Joint Surg Am 2018; 100: 496\u2013504.","DOI":"10.2106\/JBJS.17.00057"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Zhao Y, Cai Z, Tang X, et al. Preoperative denosumab may increase the risk of local recurrence of giant-cell tumor of bone treated with curettage: a systematic review and meta-analysis. J Cancer 2021; 12: 508\u201317.","DOI":"10.7150\/jca.50575"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Handy JR, Bremner RM, Crocenzi TS, et al. Expert consensus document on pulmonary metastasectomy. Ann Thorac Surg 2019; 107: 631\u201349.","DOI":"10.1016\/j.athoracsur.2018.10.028"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Xu R, Choong PFM. Metastatic giant cell tumour of bone: a narrative review of management options and approaches. ANZ J Surg 2022; 92: 691\u20136.","DOI":"10.1111\/ans.17520"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Muheremu A, Niu X. Pulmonary metastasis of giant cell tumor of bones. World J Surg Oncol 2014; 12: 261.","DOI":"10.1186\/1477-7819-12-261"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Rosario M, Kim HS, Yun JY, et al. Surveillance for lung metastasis from giant cell tumor of bone. J Surg Oncol 2017; 116: 907\u201313.","DOI":"10.1002\/jso.24739"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Tsukamoto S, Ciani G, Mavrogenis AF, et al. Outcome of lung metastases due to bone giant cell tumor initially managed with observation. J Orthop Surg Res 2020; 15: 510.","DOI":"10.1186\/s13018-020-02038-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Palmerini E, Picci P, Reichardt P, et al. Malignancy in giant cell tumor of bone: a review of the literature. Technol Cancer Res Treat 2019; 18: 1533033819840000.","DOI":"10.1177\/1533033819840000"}],"container-title":["Annals of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/32\/1\/32_cr.25-00214\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T04:18:16Z","timestamp":1769228296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/32\/1\/32_cr.25-00214\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5761\/atcs.cr.25-00214","relation":{},"ISSN":["1341-1098","2186-1005"],"issn-type":[{"value":"1341-1098","type":"print"},{"value":"2186-1005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"cr.25-00214"}}